CLINICAL_TRIALS
trial_result
· 2022-07-15
Clinical Trial Update: Combined Steroid and Cyclosporin as First-line Treatment in Adults With Primary Immune Thrombocytopenia [Phase 2]
Summary
Phase 2 trial investigating combined steroid and cyclosporin as first-line treatment for adults with immune thrombocytopenia.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Peking University People's Hospital | Conditions: Immune Thrombocytopenia | Phase 2 | Status: UNKNOWN